In June 2024, the US FDA approved pembrolizumab with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adults with primary advanced or recurrent endometrial …

Nov 24, 2025 · Pembrolizumab (Keytruda) is an immunotherapy used to treat cancers, including types of non-small cell lung cancer (NSCLC), breast cancer, melanoma, head and neck …

Pembrolizumab works by binding to the protein PD-1 on the surface of certain immune cells called T cells, which keeps cancer cells from suppressing the immune system.

Learn about KEYTRUDA® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers. Visit the patient website.

Nov 1, 2025 · Pembrolizumab injection is used in combination with pemetrexed and platinum-containing chemotherapy as a first-line treatment for malignant pleural mesothelioma (cancer …

Dec 12, 2022 · Pembrolizumab Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side …

Dec 18, 2024 · Overview: Keytruda is used to treat many types of cancer. The medicine helps to turn on the body's immune system, so it can attack cancer cells. Common side effects of …

On October 16, 2023, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) with platinum-containing chemotherapy as neoadjuvant treatment, and with …

Pembrolizumab is a type of targeted therapy that does not directly kill cancer cells but alters a specific cell mechanism that promotes cancer growth and spread. Pembrolizumab works by …

Pembrolizumab injection is in a class of medications called monoclonal antibodies. It works by helping your immune system to slow or stop the growth of cancer cells.